Experience

Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with separate private exchange offers for its existing 12% senior secured notes due 2020 held by certain holders for new…

Davis Polk advised the representatives of several initial purchasers in connection with a Rule 144A offering by Palo Alto Networks, Inc. of an aggregate principal amount of $1.5…

Davis Polk advised the initial purchaser in connection with a Rule 144A and Regulation S offering by Sea Limited of $575 million aggregate principal amount of its 2.25% convertible…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount of its 2…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by IAC FinanceCo, Inc., a wholly owned subsidiary of IAC/InterActiveCorp, of …

Davis Polk advised GAIN Capital Holdings, Inc. on a Rule 144A offering of $92 million aggregate principal amount of its 5.00% convertible senior notes due 2022, which included $12 million…

Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of 7,500,000 equity units,…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $345 million aggregate principal amount of Veeco’s 2.70% convertible senior notes due 2023, which…

Davis Polk advised the administrative agent under a $1 billion prepetition unsecured revolving credit facility, in connection with the successful cross-border restructuring of Pacific…